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ABSTRACT
Objective: To determine the frequency of restless legs syndrome (RLS) and its associated factors in patients with type
2 diabetes mellitus. Design and Methods: It was single centered, cross-sectional study done with convenient
sampling. The study population comprised 174 subjects (120 diabetics and 54 non-diabetics). Participants were
recruited from the Diabetes clinic of Jinnah Medical College Hospital, Karachi. The relevant clinical and laboratory
parameters were obtained by clinical history and chart review. Multivariable logistic regression was done to identify the
factors of RLS among diabetics. Results: Using the International RLS Study Group (IRLSSG) criteria, RLS was identified
only in 67(55.8%) subjects from the diabetic group. The mean age of RLS subjects was 56±8 years as compared to
46±8 years in the non-RLS subjects. Forty percent (26/67) of the diabetic/RLS+ subjects had diabetes for >10 years
and had significantly deranged glycemic indices. Periodic limb movements during sleep (PLMS) as reported by the bed
partner or close family member were reported by 32(26.7%) of the diabetic subjects only; of which 21(65.6%) subjects
had RLS. Sleep disturbances were more frequent among patients with RLS as compared to non-RLS (61.2% versus
21.5%). According to Semmes-Weinstein filament test, 61% of diabetics and 67% of diabetic/RLS subjects had peripheral
neuropathy. Interestingly, none of our subjects who were diagnosed as RLS was ever asked by their physician for symptoms
of RLS prior to this study. Conclusion: RLS is a common problem among patients with type 2 diabetes mellitus and is
associated with increasing age, peripheral neuropathy and impaired day time functioning. Poor recognition by physicians
result in delayed diagnosis.
Keywords: Restless leg syndrome (RLS), diabetes mellitus, polyneuropathy
INTRODUCTION

and is found to be higher in women than in men. The
intensity of sensory and motor symptoms generally
tends to increase with advancing age. Alcoholics, smokers
and selective serotonin reuptake inhibitor (SSRI) users
as well as patients suffering from neuropathy are more
likely to have RLS [2, 13-16]. Diabetes mellitus is a lifelong
disease and a common cause of sensorimotor polyneuropathy [13]. However, previous studies on RLS in
diabetic neuropathy yielded conflicting results with a
prevalence rate ranging from 8.8 to 27%, not significantly
different even from controls in some studies [11, 17-18].
Poor glycemic control with RLS may also impact the
associated consequences of diabetes mellitus including
sleep quality, sleep cycle alterations, fatigue, and
depression [19]. Norma G et al reported that diabetic
people at risk for RLS were at increased risk for obstructive
sleep apnea and insomnia-sleep problems often
reported in diabetes [19]. Montplasir et al reported
significant association between RLS and Periodic Limb
Movements during Sleep (PLMS) during sleep or while

Restless legs syndrome (RLS) is a chronic sensorimotor
disorder [1-4]. RLS can either be primary or secondary.
Primary or idiopathic RLS, diagnosed when clinical
conditions responsible for secondary forms are
excluded by laboratory and clinical examinations,
accounts for about 70 -80% of all RLS cases [1,5].
Among secondary or symptomatic forms, several conditions
such as iron deficiency anemia, uremia, pregnancy,
polyneuropathy and type 2 diabetes mellitus have been
implicated in association with RLS [6-11]. RLS has
recently been characterized by The International Restless
Legs Syndrome Study Group (IRLSSG) as a clinical
syndrome presenting as a combination of intense desire
to move the limbs associated with paresthesias/dysesthesias;
motor restlessness; exacerbation of symptoms with
inactivity and relief by activity; and a nocturnal worsening
in the symptom [12]. According to the Western data, it
affects approximately 7-11.5% of the adult population
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awake [20]. However, there is paucity of local data in this
regard. We hypothesized that patients with type 2
diabetes mellitus will show a high frequency of RLS.
Therefore, we sought to determine the frequency of RLS
in subjects with type 2 diabetes mellitus and its associated factors especially sleep disturbances, daytime
time functioning and PLMS. with non-adherence to
AEDs and help in taking possible measures to improve
antiepileptic drug compliance and prevent consequences of uncontrolled seizures. The prevalence of
epilepsy in Pakistan is about 9.99/1000.

disturbance was defined as difficulty in falling asleep
and awakening. Daytime sleepiness was assessed by
Epworth Sleepiness Scale (ESS) which is a validated
tool. A score of >10 was indicative of excessive
daytime sleepiness. [13] Patients were considered to
have daytime dysfunctioning when they have a subjective
complain about it. Presence of PLMS as reported by the
bed partner or close family member was ascertained as
described in the literature i.e. periodic jerky movements
causing flexion of the ankle, knee, or hip; occasionally
accompanied by arousals from sleep, leading to sleep
fragmentation and excessive daytime sleepiness [18].

METHODS
Patient selection
For this study, 120 consecutive subjects with type 2
diabetes mellitus who attended the diabetes clinic of
Jinnah Medical Dental College Hospital, Karachi from
July 2009 to July 2010 were recruited. Ethical approval
for the study was taken from local ethics review
committee of the hospital. The non-diabetic group
consisted of 54 consecutive patients who attended the
medical outpatient clinics for some seasonal illness
during the study period with no sign/symptom of any
chronic disease. We included all the subjects who were
30 years old or above, irrespective of the gender. We
excluded all the patients who were known to have (or
were being treated for) anemia, chronic liver disease,
thyroid dysfunction, uremia and non-diabetic polyneuropathy. Similarly, pregnant women were excluded from
the study as RLS is already expected to be more prevalent
in this set of population. Patients who had a language
barrier were also excluded to minimize the biases in
clinical findings and ensure the authenticity of information.
All the participants provided an informed consent.
General Protocol
Records were reviewed and patients were interviewed
using a closed ended questionnaire regarding their
demographic aspects, past medical history, family
history and use of medications. In particular, we
inquired about the clinical conditions which support
RLS (such as iron-deficiency anemia, hypothyroidism,
uremia, and rheumatoid arthritis) and about the drugs
which could possibly worsen RLS symptoms
(antidepressants or antipsychotics) or rather improve
RLS symptoms (dopaminergic agents, benzodiazepines,
and anticonvulsants such as gabapentin, carbamazepine,
oxcarbazepine, and valproic acid). Moreover, both
diabetic and non-diabetic subjects were specifically
asked for: (1) disturbance of sleep (2) daytime sleepiness
(3)
daytime dysfunction; and (4) presence of PLMS. Sleep
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RLS Protocol
In all the study subjects, a neurologist confirmed the
presence of RLS using the criteria defined by the International Restless Legs Syndrome Study Group (IRLSSG)
[12]
. Only the patients who fulfilled all 4 criteria were
considered affected by RLS and were further asked
about the frequency, duration and intensity of the
symptoms. Presence of RLS symptoms in first-degree
relatives was established in both diabetic and nondiabetic subjects.
Laboratory Data
Laboratory data was obtained at the time of interview
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for complete blood count, creatinine, random and
fasting blood glucose in all subjects and for serum
ferritin and glycosylated hemoglobin (HbA1c) in 79 and
152 subjects respectively.

population along with 80 percent power, 0.05 significance
level, 5 percent bond on error, and 5% adjustment for
non-response rate. As previously reported by Rozina S
et al, RLS was seen in around 10% of the general
population.[7] Data was entered and analyzed using
Statistical Package Social Sciences (SPSS) version
19.0. Initially descriptive statistics and frequencies and
proportions were generated. Continuous variables were
analyzed by t– test and categorical by chi-square or
Fisher exact, where appropriate. Later stepwise multivariable logistic regression was done to identify factors
related with RLS among diabetics.

Evaluation of polyneuropathy
Distal sensory function was examined bilaterally using
Semmes-Weinstein (SW) filaments as recommended by
the World Health Organization and International Diabetes
Federation for screening peripheral neuropathy in
diabetic subjects [21]. The dorsal surface of the foot and
the heel was tested in a random manner on 10 predetermined sites [21-22] with the filament pressed perpendicularly, for 1 second, and pressure enough to bend
the filament. Patient’s response was noted on the basis
of yes/no option. Those patients who were able to
perceive at less than 6 points were considered to have
neuropathy [21].

RESULTS
General characteristics of the diabetic and non-diabetic
subjects are presented in Table 1. Diabetic subjects
were comparably elder as compared to the non-diabetic
subjects. Also, there was a slight preponderance of
male gender in the diabetic subjects. Presence of sleep
disorders, PLMS and RLS, family history of diabetes
mellitus and RLS, and higher glycemic indices were
significantly frequent among diabetic subjects. Only
34% of the diabetic subjects had a value of HbA1c <
7%. Most of the patients (94%) were taking oral hypoglycemic agents, the rest were on insulin therapy. PLMS
were reported by 32 (26.7%) diabetics’ subjects only;
of whom 21(65%) subjects had RLS. Sixty seven of the
120 subjects with type 2 diabetes mellitus (55.8%)
were diagnosed as having RLS (p < 0.05). Among
these subjects, 28/67 (41.8%) had diabetes for <
5years, 26/67 (38.8%) for >10 years, while the rest of
them (13/67; 19.4%) had diabetes for 5-10 years. The
laboratory parameters of RLS subjects revealed higher
values for the glycemic indices including random and
fasting blood sugar; and HbA1c level (Table 2). Among
RLS subjects, none reported a positive family history of
any sleep disorder which was in contrast to 4 (3.7%) of
the non-RLS subjects. Among the subjects who did not
fulfill the RLS criteria (n;53) the individual RLS like
complains were evaluated. Unpleasant sensation in the
legs with urge to move them was reported in 42.8%,
worsening during inactivity or rest in 25.6%, relieved by
activity in 18.1% while nocturnal worsening was
reported by 22.4% of non- RLS subjects. Among RLS
subjects, the majority of the subjects were using overthe-counter analgesics (59/67; 88%). In univariate
analysis, female gender, increasing age, clinical
evidence of neuropathy, disturbance of sleep, daytime
sleepiness, and impaired daytime functioning appeared
as predictors of presence of RLS (Table 3). However,
only advancing age, impaired daytime functioning and
clinical evidence of neuropathy appeared as the predictors
of RLS in multivariate analysis (Table 4). The multivariable

Statistical Analysis
Sample size estimation: A sample size of at least 175
was required to estimate the proportion of RLS among
diabetics, however there is no literature available in our
region assuming 10-15% prevalence in the regional
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analysis showed that having impaired daytime functioning
due to sleep disorder was 47 times more associated
with RLS adjusting for other covariates (adjusted Odds
Ratio (OR) 47; 95% CI 10.3-217). Likewise, odds of
having RLS among those with an evidence of neuropathy
were 15 times more than those without neuropathy
(adjusted OR= 15, 95% CI = 3.8-58). Every one year
increase in age showed a 20% increase in risk of having
RLS after adjusting other variables (Adjusted OR= 1.2,
95% CI = 1.1-1.3). Interestingly, despite the high
prevalence reported from the subcontinent, none of the
non-diabetic subject suffered from either RLS or PLMS.
To our surprise, none of the subjects who were
diagnosed as RLS was ever asked by their physician for
symptoms or diagnosis of RLS prior to this study.

those with an evidence of neuropathy were 15 times
more than those without neuropathy (adjusted OR=
15, 95% CI = 3.8-58). Diabetic subjects who were
affected by RLS described their symptoms as an urge to
move their limbs while those who had clinical evidence
of neuropathy described their symptoms as pain,
electric, or burning (pricking) sensations. This is in
accordance with previous results shown by Winkelmann
et al and Merlino et al [4, 35] A part from neuropathy, iron
deficiency anemia is a well known contributor towards
symptomatic form of RLS.[10] Our iron studies have
shown insignificant association between RLS/diabetic+
subjects and iron studies which was in accordance with
results demonstrated by previous studies [4, 11] thus
further pointing towards a lack of association. However,
more clinic-pathological studies are needed to further
verify this hypothesis. Significant number of RLS
patients in our study reported sleep disturbance with
daytime sleepiness and impaired daytime functioning
which was consistent with results from previous studies
on diabetic subjects. We found sleep disturbance to be
associated with polyneuropathy and RLS. Similar correlation
has been demonstrated by previous other studies [11, 14,
36-37]
. Our study has shown a significant association
between RLS and PLMS as the majority of the PLMS
patients were suffering from RLS too. In addition to
diabetes, studies have also reported a significant association
of RLS with diseases such as hypertension which could
be due to concomitant sleep disturbances in such
patients [38-41]. Advancing age and polyneuropathy have
been shown to be associated with an increased prevalence of RLS [18,28]. The multivariate analysis established
this association in our subjects as well (Table 2). A large
number of our non-RLS subjects were those who
suffered from a combination of symptoms included in
the IRLSSG diagnostic criteria but they however, failed
to meet all 4 criteria to be defined as RLS. We assume
that these patients might be a potential case of RLS
and may be defined as possible or probable RLS later.
We propose that this criterion might be revised to take
into account these large number of potential RLS
patients so that early diagnosis and thus early identification
of risk factors and their treatment might help them to
enjoy a better quality of life. Interestingly, none of the
non-diabetic subject suffered from either RLS or PLMS.
Most importantly, none of our RLS subjects were ever
asked by their physician for symptoms or diagnosis of
RLS prior to this study. This may be because of the poor
awareness of RLS among physicians as well.

DISCUSSION
The reported prevalence of RLS in general population by
Western countries ranges between 5-15% [23] whereas
data from Asian countries has reported a lower prevalence
(1.5% in Japan [24], 1% in Singapore [25], 3.19% in
Turkey [26]). Recently, higher prevalence rate i.e. 9.71%
[27]
has been reported by a Turkish study but their study
population included subjects aged 40 years and above.
Population based studies have found higher prevalence
rates of RLS among subjects with advanced age,
increased body mass index, smoking and diabetes
mellitus [28,29]. Such varied differences in ranges might
be due to the reason that some have heterogeneity in
study design, study population and sample size. With
no local data in this regard from Pakistan, this is the
first Pakistani study confirming significant association
between RLS and type 2 diabetes mellitus. The
frequency of RLS in our diabetic subjects (55.8%) is
significantly higher than compared to the international
literature. Merlino et al diagnosed the RLS on the basis
of International RLS Study Group criteria and reported a
prevalence of 17.7% in their study population of
diabetic subjects [4]. Lopes et al reported a comparatively
higher frequency of RLS in 27% of the diabetic subjects
[18]
, which is still lower than the frequency we found in
our cohort. Peripheral neuropathy has been postulated
to be associated with the pathogenesis of RLS. Qu S
and Jensen et al have hypothesized that RLS in diabetic
subjects could be due to the concurrence of decreased
inhibitory dopaminergic control on the dorsal horns of
the spinal gray matter [30-31] with the excitatory nociceptive
inputs due to the peripheral neuropathy [32]. Various
clinical studies have reported a significant association
between RLS and polyneuropathy [8,33,34]. However,
Skomro et al reported an insignificant association
between RLS and diabetic polyneuropathy (p-value:
0.78) [11]. In our study, odds of having RLS among
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Our study was a single centered study so results cannot
be generalized over the whole population. Ideally the
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patients who are suspected to have neuropathy by SW
monofilament testing should undergo a standard nerve
conduction study –the gold standard for the confirmation
of neuropathy. Also, PLMS needs to be diagnosed with
standard polysomnography.

Hence, nerve conduction study (NCS/EMG) is not an
economically pliable tool for the diagnosis of sensory
neuropathy in our general community. So, SW filament
utility has again come up in our study as a useful tool.
CONCLUSION
RLS is a common problem among patients with type 2
diabetes mellitus and is associated with increasing age,
peripheral neuropathy and impaired day time functioning.
Its diagnosis is often delayed because of poor recognition
by the physicians. Early diagnosis may result in
improved quality of life of these patients. Considering a
substantial number of subjects with one or more symptoms
suggestive of RLS in the non-RLS group, further studies
with larger sample size are needed to establish the
importance of individual symptoms to guide the investigation and the therapy in this sub-set of patients.
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